Navigation Links
Existing drugs may help more breast cancer patients
Date:12/7/2012

n this modest percentage translates into more than 4,000 patients per year.

The study, led by senior author Matthew J. Ellis, MD, PhD, of Washington University, and published online Dec. 7 in the journal Cancer Discovery, analyzed data from eight DNA sequencing studies, which together included about 1,500 patients. Two of the sequencing studies were conducted by The Genome Institute at Washington University, in collaboration with study co-author Elaine R. Mardis, PhD, co-director of the genome institute.

Of the 1,500 patients, 25 were found to have HER2 mutations without gene amplification. Not all mutations appeared to have the same effect, however. After analyzing 13 of the mutations, seven were found to drive cancer growth. In the laboratory analysis, most of these mutations responded well to the anti-HER2 drugs lapatinib and trastuzumab, both approved by the U.S. Food and Drug Administration. Although two of the mutations were resistant to lapatinib in lab tests, they responded well to neratinib, a newer anti-HER2 drug that is currently in phase II clinical trials.

Bose also cautions that some mutations were found to be "silent," meaning they did not drive the tumor's growth and therefore would likely not respond to anti-HER2 drugs.

The study's findings have led directly to the launching of a phase II clinical trial to test whether patients with HER2 mutations (but not the amplification) will benefit from anti-HER2 drugs. The trial will include patients with stage IV breast cancer classified as HER2 negative. Their HER2 genes will be sequenced to look for mutations. If mutations are present, they will be treated with neratinib in addition to the standard treatment they would otherwise receive.

At Washington University, the trial will be led by Cynthia X. Ma, MD, PhD, associate professor of medicine. The other centers participating in the study are the Dana-Farber Cancer Institute, Memorial Sloan-Kettering Cance
'/>"/>

Contact: Julia Evangelou Strait
straitj@wustl.edu
314-286-0141
Washington University School of Medicine
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Scientists test 5,000 combinations of 100 existing cancer drugs to find more effective treatments
2. Existing drugs offer new treatment options for high-risk childhood leukemia subtype
3. Mahvrick Expands to Brazil, Russia, India, China to Support Existing Client Customer Growth
4. Zane Benefits Publishes Information About Over-the-Counter (OTC) Medicines, Drugs and HRAs
5. Heart Failure Drugs Put to the Test
6. More New Drugs a Bad Fit With Grapefruit, Study Finds
7. Continued Use of ADHD Drugs May Reduce Criminal Behavior, Study Says
8. UAlberta prostate cancer researcher and team developing homing beacon drugs to target cancer cells
9. Can breast cancer cells reaction to cancer drugs be predicted?
10. Quick, high-volume test offers fast track in search for Alzheimers drugs
11. Structure of enzyme unravelled providing basis for more accurate design of chemotherapeutic drugs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Existing drugs may help more breast cancer patients
(Date:8/19/2014)... (PRWEB) August 19, 2014 Grande ... named the winner of the 2014 Independent Cosmetics ... home the first place position in “Product Innovation; ... specially-formatted eyeliner, which also includes a lash enhancement ... color, plus lash-boosting technology. , This ...
(Date:8/19/2014)... 2014 In honor of National Dog Day on ... old furry friend by offering tips on caring for aging dogs. ... more. Because of this, dog owners need to realize the dog’s ... age, their needs change. They will not want to spend as ... used to. Because of this, pet owners should consider altering the ...
(Date:8/19/2014)... Following the completion of a $16 million rooms renovation in ... to debut the highly anticipated final phase of its $20 ... all public spaces to match the fresh look and feel ... experience at 1823 Kitchen and Bar and an innovative tech ... 1823 Kitchen and Bar, Grand Hyatt Tampa Bay has added ...
(Date:8/19/2014)... admitted to U.S. hospitals cannot smoke during their stay and ... few are able to stay smoke-free after returning home. ... JAMA describes a program that increased the proportion ... more than 70 percent. The system used interactive voice ... and stop-smoking medication for three months after smokers left the ...
(Date:8/19/2014)... Philadelphia, PA, August 19, 2014 Warfarin, the ... competition from new options in the anticoagulant drug ... study documents the rapid adoption of these novel ... NOACs accounted for 62% of all new anticoagulant ... drug costs. Findings are published in The ...
Breaking Medicine News(10 mins):Health News:GrandeLINER™ Wins Independent Cosmetics Manufacturers & Distributors Award 2Health News:GrandeLINER™ Wins Independent Cosmetics Manufacturers & Distributors Award 3Health News:The Puppy Store Helps Pet Owners Care for Aging Dogs 2Health News:Grand Hyatt Tampa Bay Hotel Unveils the Finishing Touches of Its $20 Million Makeover 2Health News:Extended support helps patients stay smoke-free after hospital discharge 2Health News:Novel oral anticoagulant prescriptions soar, but at a high cost 2Health News:Novel oral anticoagulant prescriptions soar, but at a high cost 3
... begun work into improving the lives of thousands of Cystic ... US-Ireland Research and Development Partnership grant. , The grant ... in the USA with funding for the Queen,s component provided ... Public Health Agency), Northern Ireland and the Medical Research Council. ...
... , THURSDAY, Feb. 3 (HealthDay News) -- A special ... disorder (ADHD) in young children, a new study suggests. ... 8 were placed on a diet containing no processed ... percent of them. And, when suspected trouble foods were ...
... bone marrow to become embryonic-like stem cells, a team ... the onset of the blood cancer leukemia in the ... blood cells obtained from a patient with leukemia," says ... directed a study aimed at generating all-purpose stem cells ...
... -- A single dose of the H1N1 swine flu vaccine ... study found. In order to assess the effectiveness of ... -- Canadian researchers looked at 552 patients with flu-like illness ... Dec. 5, 2009. Pandemic H1N1 was detected in 209 ...
... News) -- If you tend to overindulge in food and ... things you can do to ease the ill effects you ... Dr. Cynthia Yoshida offers the following suggestions: Stay ... Caffeine-free, non-carbonated drinks, such as water, can help lessen the ...
... (HealthDay News) -- The average starting salary for a female ... a huge increase from the $3,600 gap in 1999, finds ... difference isn,t known because it isn,t explained by gender differences ... researchers said. The study authors analyzed survey data from ...
Cached Medicine News:Health News:$2.8 million grant boosts cystic fibrosis research at Queen's 2Health News:Restrictive Diet May Reduce ADHD Symptoms 2Health News:Restrictive Diet May Reduce ADHD Symptoms 3Health News:Restrictive Diet May Reduce ADHD Symptoms 4Health News:New induced stem cells may unmask cancer at earliest stage 2Health News:Gender Gap in Starting Doctor Pay Grows 2
(Date:8/19/2014)... /PRNewswire-iReach/ -- ChemImage founder and CTO, Patrick J. ... an innovative diagnostic procedure for the detection of colorectal ... Disease (SPEC) conference in Krakow, Poland ... of in vitro Diagnostics for Detection of Colorectal Cancer ... conference poster session on Tuesday, August 19, 2014 from ...
(Date:8/19/2014)...  As power morcellator lawsuits continue to mount ... notes that women in need of fibroid removal ... options that do not involve the use of ... report published by The Wall Street Journal on ... mini-laparotomy and vaginal hysterectomy. Non-surgical options for shrinking ...
(Date:8/19/2014)... 2014 Research and Markets has announced ... Global Strategic Business Report" report to their offering. ... Growth Hormone Drugs in US$ Million by the following Brands: ... report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , and Rest ...
Breaking Medicine Technology:ChemImage Scientists Present Latest Developments for in vitro Detection of Colorectal Cancer Using Raman Molecular Imaging (RMI) at International Conference Focused on Biomedical Applications of Raman Spectroscopy 2As Morcellator Lawsuits Mount, Bernstein Liebhard LLP Notes Report Detailing Alternatives to Uterine Morcellation 2As Morcellator Lawsuits Mount, Bernstein Liebhard LLP Notes Report Detailing Alternatives to Uterine Morcellation 3Global Human Growth Hormone Drugs - Strategic Business Report 2014 2
... Sept. 1, 2011 Kimberly-Clark Health Care (KCHC) ... price increase on synthetic exam gloves due to ... materials, particularly butadiene and acrylonitrile.   ... raw materials along with inflationary pressures have been ...
... 1, 2011 Today, Osseon® Therapeutics, Inc. launched ... newest in Osseon,s suite of minimally invasive products ... (Photo:   http://photos.prnewswire.com/prnh/20110901/SF61461 ) The ... entire vertebral body. The Osseoplasty™ procedure offers unparalleled ...
Cached Medicine Technology:Osseon® Announces Commercial Release of Osseoflex®SN (Steerable Needle) 2
96-Well PCR Plate Sealing Mat...
Easy to pierce, remove using foil stripper...
Inquire...
... Heat Sealing Foil and Heat Sealing Film each ... allow safe and easy sample storage. In automated ... with standard pipette tips. The Heat Sealing Film ... in the plates. Heat Sealing Foil is removed ...
Medicine Products: